WadeThomasIamsMD

Oncology • Nashville, TN

Physician

Join to view full profile

Dr. Iams is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Iams' full profile

Already have an account?

Office
3601 21st Ave S
Nashville, TN 37232
Phone+1 615-322-3384

Fax+1 615-936-0605

Summary

Dr. Wade Iams is an oncologist in Nashville, TN and is affiliated with Vanderbilt University Medical Center. He received his medical degree from University of Michigan Medical School and has been in practice 5 years. He is experienced in lung cancer, melanoma, and lymphoma.

Education & Training

McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2016 - 2018
Vanderbilt University Medical CenterResidency, Internal Medicine, 2012 - 2015
University of Michigan Medical SchoolClass of 2012

Certifications & Licensure

KY State Medical License 2021 - 2025
TN State Medical License 2013 - 2025
GA State Medical License 2021 - 2022
AL State Medical License 2020 - 2021
IL State Medical License 2016 - 2020
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

263 citations
Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell ...
Young Kwang Chae, Ayush Arya, Wade T. Iams, Marcelo Rocha Cruz, Sunandana Chandra
Journal for Immunotherapy of Cancer. 2018-05-16
173 citations
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Apar Kishor P Ganti, Billy W Loo, Michael Bassetti, Collin Blakely, Anne Chiang
Journal of the National Comprehensive Cancer Network. 2021-12-01
46 citations
Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice.
Xiuning Le, Hiroshi Sakai, Enriqueta Felip, Remi Veillon, Marina Chiara Garassino
Clinical Cancer Research. 2021-11-17

Press Mentions

ASCP Proudly Celebrates the Future Leaders of Pathology and Laboratory MedicineSeptember 18th, 2017